Biology Reference
In-Depth Information
45. Cole KA et al (2008) A functional screen identifies miR-34a as a candidate neuroblastoma
tumor suppressor gene. Mol Cancer Res 6(5):735-742
46. Li N et al (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met
expression in human hepatocellular carcinoma cells. Cancer Lett 275(1):44-53
47. Raver-Shapira N et al (2007) Transcriptional activation of miR-34a contributes to p53-medi-
ated apoptosis. Mol Cell 26(5):731-743
48. Chang TC et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression
and promotes apoptosis. Mol Cell 26(5):745-752
49. Toyota M et al (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene
4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68(11):
4123-4132
50. Sun F et al (2008) Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle
arrest. FEBS Lett 582(10):1564-1568
51. Yamakuchi M, Ferlito M, Lowenstein CJ (2008) miR-34a repression of SIRT1 regulates
apoptosis. Proc Natl Acad Sci USA 105(36):13421-13426
52. Pigazzi M et al (2009) miR-34b targets cyclic AMP-responsive element binding protein in
acute myeloid leukemia. Cancer Res 69(6):2471-2478
53. Ostenfeld MS et al (2010) miR-145 induces caspase-dependent and -independent cell death
in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder
tumors. Oncogene 29(7):1073-1084
54. Chiyomaru T et al (2011) SWAP70, actin-binding protein, function as an oncogene targeting tumor-
suppressive miR-145 in prostate cancer. Prostate doi:10.1002/pros.21372. [Epub ahead of print]
55. Metzler M et al (2004) High expression of precursor microRNA-155/BIC RNA in children
with Burkitt lymphoma. Genes Chromosomes Cancer 39(2):167-169
56. Kluiver J et al (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediasti-
nal and diffuse large B cell lymphomas. J Pathol 207(2):243-249
57. Borchert GM, Holton NW, Larson ED (2011) Repression of human activation induced cyti-
dine deaminase by miR-93 and miR-155. BMC Cancer 11:347
58. Pedersen IM et al (2009) Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent
growth of B cell lymphomas. EMBO Mol Med 1(5):288-295
59. le Sage C et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-
222 promotes cancer cell proliferation. EMBO J 26(15):3699-3708
60. Medina R et al (2008) MicroRNAs 221 and 222 bypass quiescence and compromise cell
survival. Cancer Res 68(8):2773-2780
61. Garofalo M et al (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenic-
ity through PTEN and TIMP3 downregulation. Cancer Cell 16(6):498-509
62. Felli N et al (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleuke-
mic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102(50):
18081-18086
63. Schaefer A et al (2010) Diagnostic and prognostic implications of microRNA pro fi ling in
prostate carcinoma. Int J Cancer 126(5):1166-1176
64. Fornari F et al (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in
human hepatocellular carcinoma. Oncogene 27(43):5651-5661
65. Quintavalle C et al (2011) miR-221/222 overexpession in human glioblastoma increases
invasiveness by targeting the protein phosphate PTPmu. Oncogene 31(7):858-868
66. Kim YK et al (2009) Functional links between clustered microRNAs: suppression of cell-
cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37(5):
1672-1681
67. Calin GA et al (2004) Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999-3004
68. Wang D et al (2010) Human microRNA oncogenes and tumor suppressors show significantly
different biological patterns: from functions to targets
.
PLoS One 5(9) pii:e13067
Search WWH ::
Custom Search